Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-to-start of anticoagulant therapy and mortality in pulmonary embolism.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Weight Change Between Pregnancies and Mortality Over 50 Years of Follow-Up.

Obesity (Silver Spring, Md.)·2026
Same author

Prevalence of inflammatory bowel disease across states: estimates based on claims database.

Inflammatory bowel diseases·2026
Same author

Impact of empiric potassium supplementation on mortality, sudden cardiac arrest and stroke in furosemide initiators.

British journal of clinical pharmacology·2026
Same author

Comparison of the somatic mutations in breast carcinomas in sporadic and BRCA1 carrier patients through targeted next generation sequencing.

Human pathology·2026
Same author

Postradiation angiosarcoma of the breast: a 25-year single-institution analysis of clinicopathological characteristics and immunohistochemical biomarker study.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2026

Related Experiment Video

Updated: Jun 4, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Genetic warfarin dosing: tables versus algorithms.

Brian S Finkelman1, Brian F Gage, Julie A Johnson

  • 1Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, USA.

Journal of the American College of Cardiology
|January 29, 2011
PubMed
Summary
This summary is machine-generated.

Formal pharmacogenetic algorithms provide the most accurate warfarin dosing compared to genetic tables and clinical methods. While genetic tables improve upon empiric dosing, algorithms offer superior precision for personalized warfarin therapy.

More Related Videos

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Related Experiment Videos

Last Updated: Jun 4, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

  • Pharmacogenomics
  • Drug Dosing Optimization
  • Clinical Pharmacology

Background:

  • Warfarin dosing is complex, influenced by genetic and clinical factors.
  • Pharmacogenetic algorithms offer predictive accuracy but involve complex calculations.
  • Genotype-stratified warfarin dosing tables, recently FDA-approved, provide a simpler alternative.

Purpose of the Study:

  • To compare the accuracy of genotype-stratified warfarin dosing tables against formal pharmacogenetic algorithms.
  • To evaluate the clinical utility of the U.S. Food and Drug Administration (FDA)-approved warfarin dosing table.
  • To determine the most accurate method for predicting stable warfarin doses.

Main Methods:

  • Retrospective cohort study of 1,378 patients with stable warfarin doses and complete genetic/clinical data.
  • Comparison of five dose prediction methods: empiric dosing, clinical algorithm, warfarin label table, genotype mean dose table, and a formal pharmacogenetic algorithm.
  • Accuracy assessed by the proportion of patients with predicted doses within 20% of actual therapeutic doses; McNemar's chi-square test used for comparison.

Main Results:

  • Formal pharmacogenetic algorithms achieved the highest accuracy (52%) in predicting warfarin dose.
  • Genotype-stratified tables (warfarin label: 43%, genotype mean dose: 44%) were more accurate than empiric (37%) or clinical algorithms (39%).
  • All comparisons showed statistically significant differences (p < 0.001).

Conclusions:

  • Formal pharmacogenetic algorithms are the most accurate method for warfarin dose prediction.
  • Genotype-stratified tables offer an improvement over empiric dosing but are less accurate than algorithms.
  • The findings support the use of formal pharmacogenetic algorithms for optimizing warfarin therapy.